- Home
- SLRN
SLRN
ACELYRIN INC.
as 03-31-2025 2:43pm EST
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | AGOURA HILLS |
| Market Cap: | N/A | IPO Year: | 2023 |
| Target Price: | $9.60 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Hold | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.50 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.84 - $7.25 | Next Earning Date: | 03-19-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 267.11% | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of ACELYRIN INC. (SLRN)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Murugan Amar | SLRN | Chief Legal Officer | Mar 17 '25 | Sell | $2.74 | 3,913 | $10,737.27 | 121,587 | |
| Mpofu Shephard | SLRN | Chief Medical Officer | Mar 17 '25 | Sell | $2.74 | 3,211 | $8,810.98 | 121,789 | |
| Kim Mina | SLRN | Chief Executive Officer | Mar 17 '25 | Sell | $2.74 | 17,986 | $49,353.58 | 671,753 |
Latest ACELYRIN INC. News
SLRN Breaking Stock News: Dive into SLRN Ticker-Specific Updates for Smart Investing
Insider Monkey
13 days ago
Acelyrin, Inc. (SLRN): One of the Best Short-Term Stocks to Buy Right Now
BioPharma Dive
17 days ago
Makary advances to full senate vote; Acelyrin, Pliant adopt ‘poison pills’
MT Newswires
18 days ago
Acelyrin Adopts Stockholder Rights Plan; Shares Up Pre-Bell
GlobeNewswire
18 days ago
ACELYRIN Adopts Limited-Duration Stockholder Rights Plan
Simply Wall St.
19 days ago
3 Promising Penny Stocks With Over $100M Market Cap
Insider Monkey
24 days ago
Is Acelyrin, Inc. (SLRN) the Best Micro Cap Stock to Buy Now?
MT Newswires
a month ago
Sector Update: Health Care Stocks Lower Tuesday Afternoon
MT Newswires
a month ago
Acelyrin Reaffirms Merger Deal With Alumis
Compare SLRN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SLRN ACELYRIN INC. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.